VETMAB BIOSCIENCES
Vetmab Biosciences is a veterinary company that currently operates in stealth mode.
VETMAB BIOSCIENCES
Industry:
Biotechnology Pet Veterinary
Founded:
2022-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.vetmab.bio
Total Employee:
1+
Status:
Active
Contact:
619-723-6476
Total Funding:
2 M USD
Technology used in webpage:
Cloudflare Hosting
Similar Organizations
28 by Evie
28 by Evie is a women’s fitness company that currently operates in stealth mode.
Bond Pet Foods
Bond Pet Foods makes pet food from real animal protein, without the animal by working with biotechnology.
Embark
Embark offers dog DNA testing that ends preventable diseases in dogs.
EverVet Partners
EverVet Partners specializes in the acquisition and development of independent veterinary hospitals.
Kindred Biosciences
Kindred Biosciences is a veterinary biotechnology company that focuses on developing therapies for dogs, cats and horses.
PetDx
PetDx is a molecular diagnostics company dedicated to the detection and treatment of cancer in pets.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Spectre Primer Technologies
Spectre Primer Technologies is a company that currently operates in stealth mode.
Thunder Road Surgical
Thunder Road Surgical is a healthcare company that currently operates in stealth mode.
Official Site Inspections
http://www.vetmab.bio
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Vetmab Biosciences"
Vetmab Biosciences
At VETmAb BIO, we’re taking advantage of human validated targets and designing them specifically for dogs and cats, thereby mitigating technical risk. By utilizing our proprietary …See details»
About - Vetmab Biosciences
As the founding team of VETmAb BIO, we intend to take every learning and best practice to bring innovative therapeutics to veterinarians who treat our dog and cat family members. At …See details»
Our Science - Vetmab Biosciences
VETmAb BIO scientists are pioneers in mAb technology with a proven track record. Our lead candidates are monoclonal antibodies and bispecific antibodies — a type of monoclonal antibody that has been engineered to bind to two …See details»
VETmAb Biosciences, Inc. | LinkedIn
VETmAb BIO is a veterinary biopharmaceutical company focused on developing monoclonal antibodies ("mAbs") to treat debilitating diseases in dogs and cats. While monoclonal antibodies have...See details»
Vetmab Biosciences - Crunchbase Company Profile & Funding
Vetmab Biosciences is a veterinary company that currently operates in stealth mode. Where is Vetmab Biosciences's headquarters? Vetmab Biosciences is located in San Diego, California, …See details»
Vetmab Bio Company Profile 2024: Valuation, Funding & Investors …
Developer of therapeutic drugs designed to bring safe and effective mAb therapies to treat animal diseases. The company focuses on developing life-improving drugs for crippling and hard-to …See details»
Vetmab Biosciences, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Vetmab Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
VETmAb Biosciences’ Bow-Wow Biz - San Diego Business Journal
May 31, 2023 · VETmAb Biosciences, Inc. Founded: 2022 CEO: Denise Bevers Headquarters: San Diego Business: Biopharmaceutical company developing monoclonal antibody …See details»
Vetmab Biosciences - Company Profile - Tracxn
Aug 25, 2024 · Vetmab Biosciences - Developer of drugs to treat animal diseases. Raised a total funding of $2.58M over 2 rounds from 1 investor. Founded by Denise Bevers, Hangjun Zhan …See details»
VETmAb Biosciences, Inc. on LinkedIn: At VETmAb BIO, we believe …
Join us in our mission to provide tailored, effective treatments that will transform the lives of our animal companions. Together, we can make a difference in the world of veterinary medicine. …See details»
Vetmab Biosciences - Products, Competitors, Financials, …
Vetmab Biosciences focuses on the development of therapeutics in the veterinary sector. The company's main offerings include the development of monoclonal antibodies (mAbs) therapies …See details»
Vetmab Biosciences - Funding, Financials, Valuation & Investors
Vetmab Biosciences is a veterinary company that currently operates in stealth mode.See details»
Contact Us - Vetmab Biosciences
STAY CONNECTED WITH US Receive research updates, clinical trial information, and more. " *" indicates required fieldsSee details»
VETmAb Biosciences, Inc. on LinkedIn: VETmAb BIO is committed …
VETmAb BIO is committed to developing safe and effective monoclonal antibody (mAb) therapies for our canine and feline family members. While numerous mAbs have been developed for use …See details»
Site Map - Vetmab Biosciences
[email protected]. Home Our Science About Contact. This site is protected by reCAPTCHA and the Google ...See details»
VETmAb Biosciences, Inc. on LinkedIn: VETmAb BIO is a small …
VETmAb BIO is a small biotech company with a deep pipeline. Want to know more? We'd love to talk! Reach out: https://lnkd.in/euRn6YkB. A groundbreaking biotech platform is coming soon. …See details»
Vetmab Biosciences, Inc. - fund raising filing - Form Ds
Vetmab Biosciences, Inc. - Most recent fund raising on December 5, 2023 raised $575,000 in Equity.See details»
VETmAb Biosciences, Inc. on LinkedIn: #vetmab #biotechnology # ...
Our focus: developing groundbreaking monoclonal antibodies to treat a wide range of animal health issues. Our dedicated research and development team has successfully created …See details»
Web Accessibility - Vetmab Biosciences
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features. Analytical cookies …See details»
VETmAb Biosciences, Inc. on LinkedIn: VETmAb BIO is exploring …
Bispecific antibodies are a type of monoclonal antibody that is engineered to bind two different antigens to the same antibody. Read more about the science behind VETmAb BIO at...See details»